- Home
- DSP vs SCPH Comparison
DSP vs SCPH Comparison
Compare DSP & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSP
- SCPH
- Stock Information
- Founded
- DSP 1999
- SCPH 2013
- Country
- DSP United States
- SCPH United States
- Employees
- DSP N/A
- SCPH N/A
- Industry
- DSP EDP Services
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- DSP Technology
- SCPH Health Care
- Exchange
- DSP Nasdaq
- SCPH Nasdaq
- Market Cap
- DSP 220.3M
- SCPH 299.0M
- IPO Year
- DSP 2021
- SCPH 2017
- Fundamental
- Price
- DSP $9.73
- SCPH $5.63
- Analyst Decision
- DSP Strong Buy
- SCPH Buy
- Analyst Count
- DSP 9
- SCPH 3
- Target Price
- DSP $20.44
- SCPH $12.00
- AVG Volume (30 Days)
- DSP 248.7K
- SCPH 2.3M
- Earning Date
- DSP 11-11-2025
- SCPH 11-12-2025
- Dividend Yield
- DSP N/A
- SCPH N/A
- EPS Growth
- DSP N/A
- SCPH N/A
- EPS
- DSP 0.13
- SCPH N/A
- Revenue
- DSP $318,471,000.00
- SCPH $49,969,000.00
- Revenue This Year
- DSP $16.28
- SCPH $108.95
- Revenue Next Year
- DSP $15.43
- SCPH $78.30
- P/E Ratio
- DSP $74.73
- SCPH N/A
- Revenue Growth
- DSP 30.92
- SCPH 107.79
- 52 Week Low
- DSP $9.07
- SCPH $1.94
- 52 Week High
- DSP $26.33
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- DSP 38.08
- SCPH 64.37
- Support Level
- DSP $9.63
- SCPH $4.33
- Resistance Level
- DSP $10.45
- SCPH $5.62
- Average True Range (ATR)
- DSP 0.37
- SCPH 0.05
- MACD
- DSP 0.11
- SCPH 0.01
- Stochastic Oscillator
- DSP 11.11
- SCPH 93.75
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.